New nanoparticle drug shows promise for Hard-to-Treat cancers
Disease control
Completed
This early-stage study tested a new drug called SNB-101 in 21 people with advanced solid tumors (like colorectal, breast, or lung cancer) that had stopped responding to standard treatments. The drug is a nanoparticle version of a chemotherapy agent, given through an IV, and the m…
Phase: PHASE1 • Sponsor: SN BioScience • Aim: Disease control
Last updated May 26, 2026 05:04 UTC